HemostOD logo — Inspired by platelet biology to save lives.

HemostOD

Inspired by platelet biology to save lives.

Founded 2020 Switzerland Lausanne, Switzerland 8 employees Debt Financing Total: $2.20M Biotechnology, Manufacturing

General Information

Company Name HemostOD
Founded Year 2020
Location Switzerland Lausanne, Switzerland +1
Employees 8
Industries Biotechnology, Manufacturing
Funding Stage Debt Financing
Social

Get notified when HemostOD moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About HemostOD

Hemostod is a biotechnology and manufacturing startup based in Switzerland, founded in 2020. The company's slogan, "Inspired by platelet biology to save lives," encapsulates its mission to utilize cutting-edge biotechnology in platelet engineering and manufacturing. In line with this vision, the company secured a Fr.1.70M Seed Round investment on 02 September 2021, with the backing of Orenok Holdings as the lead investor. Hemostod's focus on platelet biology presents a promising opportunity within the biotechnology and healthcare sectors, addressing critical needs in the field of blood-related therapies. The company's innovative approach, backed by recent investment, positions it well for further advancements in the space. As Hemostod continues to leverage its expertise in biotechnology and manufacturing, the recent Seed Round investment is instrumental in fueling the company's growth and R&D initiatives, ultimately driving impactful contributions to the field of life-saving biotechnologies.

Taxonomy: platelets, bioengineering, stem cells, on demand, in vitro manufacturing, bioprocess, blood cancer, leukemia, transfusion, hematology, biologics, drug development, targeted drug delivery

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• 1 •••• •••• 11 Jun 2024
Seed Round •••••• 1 •••• •••• 02 Sep 2021

HemostOD Alternatives & Competitors

HemostOD vs

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...

Series B
Biotechnology, Health Care
HemostOD vs

Addressing compelling needs in injectable drug delivery

8 employees
HemostOD vs

Drug and alcohol testing programs for large and small employers.

21 employees
Biotechnology, Health Care

FAQ About HemostOD

Inspired by platelet biology to save lives.
HemostOD was founded in 2020.
HemostOD is headquartered in Lausanne, Switzerland.
HemostOD operates in the following industries: Biotechnology, Manufacturing.
HemostOD has approximately 8 employees.
HemostOD has completed 2 funding rounds, raising a total of $2.20M. The latest funding stage is Debt Financing.
Top alternatives and competitors to HemostOD include Bostal Drug Delivery, Congruence Medical Solutions, National Drug Screening, Inc., METiS Pharmaceuticals, Forensic Fluids Laboratories. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HemostOD and Bostal Drug Delivery are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors HemostOD and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy